Naitive Technologies, Ltd.
United KingdomFDA 510(k) applicant, unverified FDA
- Devices
- 2
- Registrations
- FDA
- FDA recalls
- 0
At a glance
Market reach
- United States
- FDA establishment
What Naitive Technologies, Ltd. makes
Native Technologies, Ltd. manufactures the OsteoSight™ Hip, a diagnostic imaging device designed for evaluating hip joint conditions, including osteoarthritis and structural abnormalities.
The OsteoSight™ Hip is classified as a Class II medical device in the US and is listed under the FDA’s 510(k) pathway. The company is based in the United States.
Catalogue
- GUDID
OsteoSight™ Hip (v1) Ref K251408
510(k) 510(k)
FDA establishments
- Naitive Technologies Ltd Cambridge Cambridgeshire · GB FEI 3041277558
Frequently asked questions
How many devices does Naitive Technologies, Ltd. have in the registry?
The registry currently lists 2 devices for Naitive Technologies, Ltd.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Naitive Technologies, Ltd.'s devices?
Among its 2 most recently registered devices, Naitive Technologies, Ltd. has devices listed in FDA 510(k) (1 device) and FDA GUDID (1 device). A device can be listed in more than one registry, so these counts overlap.
What risk classes do Naitive Technologies, Ltd.'s devices fall under?
Among its 2 most recently registered devices, the classes recorded for Naitive Technologies, Ltd.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Naitive Technologies, Ltd. in the registry?
The most recently registered devices listed for Naitive Technologies, Ltd. include OsteoSight v1 and OsteoSight™ Hip (v1).
Which FDA establishments are linked to Naitive Technologies, Ltd.?
1 FDA establishment is linked to Naitive Technologies, Ltd. in the registry; they are listed on the company page.